Kalos Management adds Natus Medical Inc (BABY) to its portfolio

Natus Medical Inc (BABY) : Kalos Management added new position in Natus Medical Inc during the most recent quarter end. The investment management firm now holds 8,954 shares of Natus Medical Inc which is valued at $343,834 , the company said in a statement filed on Aug 1, 2016 with the SEC.Natus Medical Inc makes up approximately 0.26% of Kalos Management’s portfolio.

Other Hedge Funds, Including , Rice Hall James Associates reduced its stake in BABY by selling 7,252 shares or 1.47% in the most recent quarter. The Hedge Fund company now holds 486,155 shares of BABY which is valued at $19,446,200. Natus Medical Inc makes up approx 1.07% of Rice Hall James Associates’s portfolio.Confluence Investment Management boosted its stake in BABY in the latest quarter, The investment management firm added 42,928 additional shares and now holds a total of 69,675 shares of Natus Medical Inc which is valued at $2,787,000. Natus Medical Inc makes up approx 0.07% of Confluence Investment Management’s portfolio.Farmers Merchants Investments Inc boosted its stake in BABY in the latest quarter, The investment management firm added 33 additional shares and now holds a total of 187 shares of Natus Medical Inc which is valued at $7,381.

Natus Medical Inc opened for trading at $38.64 and hit $39.99 on the upside on Thursday, eventually ending the session at $38.44, with a gain of 0.10% or 0.04 points. The heightened volatility saw the trading volume jump to 1,31,706 shares. Company has a market cap of $1,273 M.

On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.

Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *